5LD-32019-10601

2 vaccinations 5 coded responses 7 check-ins 5 free-text entries 3 call cases

Sex: Male
Age at first dose: 51-55
ZIP prefix: 011 / MA
Registered: 2021-06-11

Relationship: Self
Race: Other
Ethnicity: Hispanic or Latino

Possible VAERS report

VAERS ID	Confidence	Score	Runner-up	Shared symptoms	Dose	State	VAERS vaccinated / onset / received	Call case
1420227 (opens in a new window)	high	9 / 11	—	2 of 12 VAERS symptoms	same dose (2)	MA matches	2021-05-23 / 2021-05-30 / 2021-06-23 received 15 days before the last call	case 825354

From the VAERS matching of call center cases (loader/vaers_match_*). Only the best match is shown, and only if it scores 8 or more out of 11. The score adds up timing (VAERS received soon after the call center contact), dose and shared symptoms; state only breaks ties. Confidence is high when the score is 8+ and at least 3 points ahead of the runner-up, medium when 5+ and 2 ahead, otherwise low. A match is a likely link, not a confirmed one.

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-04-25
Dose 1 — Moderna
2021-05-23
Dose 2 — Moderna
2021-06-11
Registered in v-safe
2021-06-11
Survey response — day 14, dose 2
MedDRA: Muscular weakness, Polymyositis — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Diagnosed with polymyositis. Weakness of leg, hip and back muscles .

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-06-11
Report sent to call center — day 14, dose 2
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

1 call case(s)
2021-06-13
Health check-in — day 21, dose 2
Feeling: Poor

Adult check-in
2021-06-20
Survey response — day 28, dose 2
MedDRA: Asthenia, Back pain, Insomnia, Polymyositis — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit

Free text: Experiencing more upper body weakness and lower back ache. Not able to sleep thru the night due to insomnia, sleeping about 3 to 5 hours a night. Being treated for polymiositis with 20 mg prednisone and 200 mghydroxychloriquine, both twice a day.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-06-20
Report sent to call center — day 28, dose 2
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

1 call case(s)
2021-06-22
Call 1 — Left Voicemail
2021-06-23
Call successful
Completed over the phone
2021-06-29
Survey response — day 35, dose 2
MedDRA: Unevaluable event — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: I experienced an allergic reaction to the hydroxychloroquine. Am now resting and awaiting for the rash to go away from my neck, chest and back. My walking and stability doing stairs has not improved. Unable to sit for long periods.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-07-04
Survey response — day 42, dose 2
MedDRA: Adverse drug reaction, Contusion, Dermatomyositis, Insomnia, Medical counselling, Office visit, Rash — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Symptoms: Now diagnosed as polidermamiositis. Experiencing rashes, bruises and breakout on face. Scheduling a CTA for a possible PE, scheduling a biopsy of muscle tissue, as well additional blood tests. Cannot sleep more than 3 or 4 hours at night due to meds. · Healthcare visit (other): Follow up appointment with my rheumatologist as well as a phone check in with my primary doctor.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-07-04
Report sent to call center — day 42, dose 2
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

1 call case(s)
2021-07-08
Call successful
Reported to VAERS during previous contact from GDIT
2021-07-28
Call 1 — Left Voicemail
2021-08-22
Survey response — 3 months, dose 2
MedDRA: Back pain, Heat therapy, Muscle atrophy, Protein total abnormal, Self-medication — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: Experienced a lot of muscle pain in my back, as my protein levels are gradually returning to normal and the muscle tissue regenerates. My prednisone dosage has been decreased to 30 mg a day now. Taking Tylenol for the pai and heating pad, as needed.

MedDRA releases: 2021-09,2024-11 · check-in free text available
2021-11-21
Health check-in — 6 months, dose 2
Feeling: Fair

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-04-25	Moderna
2	2021-05-23	Moderna

Call center

3 call center cases

3 successful

VAERS report filed, before or during a call: 3

See the call center timeline

Free text

Release 9 — day 14, dose 2

2021-06-11

Symptoms: Diagnosed with polymyositis. Weakness of leg, hip and back muscles .

Release 9 — day 28, dose 2

2021-06-20

Symptoms: Experiencing more upper body weakness and lower back ache. Not able to sleep thru the night due to insomnia, sleeping about 3 to 5 hours a night. Being treated for polymiositis with 20 mg prednisone and 200 mghydroxychloriquine, both twice a day.

Release 9 — day 35, dose 2

2021-06-29

Symptoms: I experienced an allergic reaction to the hydroxychloroquine. Am now resting and awaiting for the rash to go away from my neck, chest and back. My walking and stability doing stairs has not improved. Unable to sit for long periods.

Release 9 — day 42, dose 2

2021-07-04

Symptoms: Now diagnosed as polidermamiositis. Experiencing rashes, bruises and breakout on face. Scheduling a CTA for a possible PE, scheduling a biopsy of muscle tissue, as well additional blood tests. Cannot sleep more than 3 or 4 hours at night due to meds. cut off by CDC

Healthcare visit (other): Follow up appointment with my rheumatologist as well as a phone check in with my primary doctor.

Release 9 — 3 months, dose 2

2021-08-22

Symptoms: Experienced a lot of muscle pain in my back, as my protein levels are gradually returning to normal and the muscle tissue regenerates. My prednisone dosage has been decreased to 30 mg a day now. Taking Tylenol for the pai and heating pad, as needed. cut off by CDC

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
HCVO	Medical counselling	✓	✓	✓
HCVO	Office visit	✓	✓	✓
SD	Adverse drug reaction	✓	✓	✓
SD	Asthenia	✓	✓	✓
SD	Back pain	✓	✓	✓
SD	Contusion	✓	✓	✓
SD	Dermatomyositis	✓	✓	✓
SD	Heat therapy	✓	·	✓
SD	Insomnia	✓	✓	✓
SD	Muscle atrophy	✓	·	✓
SD	Muscular weakness	✓	✓	✓
SD	Polymyositis	✓	✓	✓
SD	Protein total abnormal	✓	·	✓
SD	Rash	✓	✓	✓
SD	Self-medication	✓	·	✓
SD	Unevaluable event	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release